This is an application for renewal of a longstanding program for predoctoral training in Pharmacological Sciences. Eight training slots are requested to support students in their first two years. The program seeks to meet the need for well-trained scientists who can maintain rapid progress in applying advances in biology to medicine. Rigorous training in molecular biology, genetics, biochemistry, structural biology, and cell biology, as well as pharmacology, forms the foundation of the program. These many disciplines are reflected in the research activities and classes offered to the students. The training program is conducted under the aegis of the Biological and Biomedical Sciences (BBS) graduate program at Harvard Medical School. BBS draws its faculty members from various basic science departments and their affiliates, and the training program faculty is a subset of this group. The central department for this program is Biological Chemistry and Molecular Pharmacology, although faculty members from other departments play important roles in the training program. The various departments and the training grant faculty are highly interactive. The research activities of the training grant faculty span a broad spectrum of pharmacological sciences with multiple areas of research strength. Students in the program are closely advised and monitored. In their first year, they take core courses covering multiple disciplines in basic biomedical sciences including pharmacological sciences, and a course that stresses reading original research papers and critical thinking. They are then required to take an advanced pharmacology course. Other courses offered include advanced courses in pharmacological sciences and/or human biology, which also stress critical thinking and the primary literature. Full time thesis research follows course work, laboratory rotations, and qualifying examinations. Students receive training in teaching, and participate in multiple other training activities including a yearly Science Day, seminars, journal clubs, and data presentation. This training plan should ensure the strengthening of a program that aims to train students who can play leadership roles in pharmacological sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007306-35
Application #
7825278
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
1975-07-01
Project End
2011-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
35
Fiscal Year
2010
Total Cost
$341,235
Indirect Cost
Name
Harvard University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Amin, Palak; Florez, Marcus; Najafov, Ayaz et al. (2018) Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNF?-mediated apoptosis. Proc Natl Acad Sci U S A 115:E5944-E5953
Brown, Adam S; Kong, Sek Won; Kohane, Isaac S et al. (2016) ksRepo: a generalized platform for computational drug repositioning. BMC Bioinformatics 17:78
German, Natalie J; Yoon, Haejin; Yusuf, Rushdia Z et al. (2016) PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2. Mol Cell 63:1006-20
Levine, Zebulon G; Walker, Suzanne (2016) The Biochemistry of O-GlcNAc Transferase: Which Functions Make It Essential in Mammalian Cells? Annu Rev Biochem 85:631-57
Brown, Adam S; Patel, Chirag J (2015) aRrayLasso: a network-based approach to microarray interconversion. Bioinformatics 31:3859-61
Chiasson-MacKenzie, Christine; Morris, Zachary S; Baca, Quentin et al. (2015) NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin. J Cell Biol 211:391-405
Barclay, Lauren A; Wales, Thomas E; Garner, Thomas P et al. (2015) Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. Mol Cell 57:873-886
Malone, Clare F; Fromm, Jody A; Maertens, Ophélia et al. (2014) Defining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers. Cancer Discov 4:1062-73
Herman, Jonathan D; Rice, Daniel P; Ribacke, Ulf et al. (2014) A genomic and evolutionary approach reveals non-genetic drug resistance in malaria. Genome Biol 15:511
Dickson, John R; Kruse, Carla; Montagna, Daniel R et al. (2013) Alternative polyadenylation and miR-34 family members regulate tau expression. J Neurochem 127:739-49

Showing the most recent 10 out of 35 publications